Recombinant adeno-associated viruses for delivering gene editing molecules to embryonic cells
Abstract:
The disclosure, in some aspects, relates to methods and compositions for recombinant adeno-associated virus (rAAV)-mediated delivery of genome editing molecules to a pre-implantation embryo.
Information query
Patent Agency Ranking
0/0